DNA ploidy and S-phase fraction as predictive factors of response and outcome following neoadjuvant methotrexate, vinblastine, epirubicin and cisplatin (M-VEC) chemotherapy for invasive bladder cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples